APPLICATION
ANDA065170
TYPE
ANDA
ORIGINAL APPROVAL
2005-09-23
LATEST ACTION
2021-07-21
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription
Products
MUPIROCINPrescription
MUPIROCIN 2% · OINTMENT · TOPICAL
Approval history
2021-07-21Labeling · Supplement 15 · standardAP
2021-07-21Labeling · Supplement 14 · standardAP
2015-11-18Labeling · Supplement 12 · standardAP
2015-11-18Labeling · Supplement 13 · standardAP
2005-09-23OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.